Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice - Quiz - MDSpire

Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice

  • By

  • Jensen Yeung

  • Parbeer Grewal

  • Mark Legault

  • Jason Stacey

  • Irina Turchin

  • June 20, 2026

  • 0 min

Share

Original Source(s)

Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice

  • by Jensen Yeung, Parbeer Grewal, Mark Legault, Jason Stacey, Irina Turchin

  • June 20, 2026

Related Content

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

Autohemotherapy combined with other external treatments of Traditional Chinese Medicine for chronic urticaria: a systematic review and meta-analysis

Transdermal entry of a non-pathogenic filamentous fungus Aspergillus oryzae induces an immunomodulatory response in skin-draining lymph nodes